Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines

被引：0
|
作者：
Yasmin M. Attia
Hanan S. EL-Abhar
Mahmoud M. Al Marzabani
Samia A. Shouman
机构：
[1] National Cancer Institute,Pharmacology Unit, Cancer Biology Department
[2] Cairo University,Pharmacology and Toxicology Department, Faculty of Pharmacy
[3] Cairo University,undefined
来源：
BMC Cancer | / 15卷
关键词：
Breast cancer; Tamoxifen; 3-bromopyruvate; Apoptosis; Angiogenesis; MMPs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Is Pyruvylated during 3-Bromopyruvate Mediated Cancer Cell Death
    Ganapathy-Kanniappan, Shanmugasundaram
    Geschwind, Jean-Francois H.
    Kunjithapatham, Rani
    Buijs, Manon
    Vossen, Josephina A.
    Tchernyshyov, Irina
    Cole, Robert N.
    Syed, Labiq H.
    Rao, Pramod P.
    Ota, Shinichi
    Vali, Mustara
    ANTICANCER RESEARCH, 2009, 29 (12) : 4909 - 4918
  • [22] 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells
    Sun, Xiaodong
    Sun, Guohui
    Huang, Yaxin
    Hao, Yuxing
    Tang, Xiaoyu
    Zhang, Na
    Zhao, Lijiao
    Zhong, Rugang
    Peng, Yongzhen
    BIOCHEMICAL PHARMACOLOGY, 2020, 177
  • [23] Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer
    Buijs, Manon
    Vossen, Josephina A.
    Geschwind, Jean-Francois H.
    Ishimori, Takayoshi
    Engles, James M.
    Acha-Ngwodo, Obele
    Wahl, Richard L.
    Vali, Mustafa
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 120 - 123
  • [24] Specificity of the anti-glycolytic activity of 3-bromopyruvate confirmed by FDG uptake in a rat model of breast cancer
    Manon Buijs
    Josephina A. Vossen
    Jean-Francois H. Geschwind
    Takayoshi Ishimori
    James M. Engles
    Obele Acha-Ngwodo
    Richard L. Wahl
    Mustafa Vali
    Investigational New Drugs, 2009, 27
  • [25] 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway
    Liu, Zhe
    Zhang, Yuan-Yuan
    Zhang, Qian-Wen
    Zhao, Su-Rong
    Wu, Cheng-Zhu
    Cheng, Xiu
    Jiang, Chen-Chen
    Jiang, Zhi-Wen
    Liu, Hao
    ANTI-CANCER DRUGS, 2014, 25 (04) : 447 - 455
  • [26] Regulation of the Proliferation of Colon Cancer Cells by Compounds that Affect Glycolysis, Including 3-Bromopyruvate, 2-Deoxyglucose and Biguanides
    Lea, Michael A.
    Qureshi, Mehreen S.
    Buxhoeveden, Michael
    Gengel, Nicolette
    Kleinschmit, Jessica
    desBordes, Charles
    ANTICANCER RESEARCH, 2013, 33 (02) : 401 - 407
  • [27] Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate
    Yadav, Saveg
    Pandey, Shrish Kumar
    Goel, Yugal
    Temre, Mithlesh Kumar
    Singh, Sukh Mahendra
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [28] Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
    Fan, Tengjiao
    Sun, Guohui
    Sun, Xiaodong
    Zhao, Lijiao
    Zhong, Rugang
    Peng, Yongzhen
    CANCERS, 2019, 11 (03)
  • [29] 3-Bromopyruvate and sodium citrate induce apoptosis in human gastric cancer cell line MGC-803 by inhibiting glycolysis and promoting mitochondria-regulated apoptosis pathway
    Guo, Xingyu
    Zhang, Xiaodong
    Wang, Tingan
    Xian, Shulin
    Lu, Yunfei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 475 (01) : 37 - 43
  • [30] Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy
    Hao, Mingang
    Weng, Xiaoling
    Wang, Yingying
    Sun, Xueqin
    Yan, Tingting
    Li, Yu
    Hou, Lidan
    Meng, Xiangjun
    Wang, Jianhua
    BIOCHEMICAL PHARMACOLOGY, 2018, 147 : 128 - 140
12345